The simultaneous prominence of the three types cells, CD8+ T cells, activated CD4+ memory T cells and M1 macrophages, implying that co-mutation of FAT3 and LRP1B can be used to predict the cytotoxic effect of lymphocytes against tumor cells and the beneficial response of immunotherapy in LUAD. Here, FAT3 is linked to neoplasm.